Hangzhou Tigermed Consulting Co., Ltd., a prominent company in the field of contract research, provides clinical trial services in the biopharmaceutical industry. Its primary function is to facilitate the process of drug development by offering comprehensive solutions ranging from clinical research and trial management to regulatory affairs. With a focus on high-quality service delivery, Tigermed supports biotechnology and pharmaceutical companies in navigating the complex landscape of clinical trials. The company impacts critical areas such as oncology, infectious diseases, and cardiovascular health, providing essential capabilities that accelerate the path to market for new therapeutics. Founded in 2004 and headquartered in Hangzhou, China, Tigermed plays a significant role in the pharmaceutical and healthcare sectors globally. It operates through a network of subsidiaries and strategic partnerships, demonstrating substantial influence in the clinical research organization industry. Tigermed's growing presence in Asia, along with its expansion into international markets, underscores its importance as a pivotal player in supporting the development of innovative medical treatments that improve health outcomes worldwide.